1. Home
  2. IRWD vs ITRG Comparison

IRWD vs ITRG Comparison

Compare IRWD & ITRG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ironwood Pharmaceuticals Inc.

IRWD

Ironwood Pharmaceuticals Inc.

N/A

Current Price

$4.83

Market Cap

578.3M

Sector

Health Care

ML Signal

N/A

Logo Integra Resources Corp.

ITRG

Integra Resources Corp.

N/A

Current Price

$1.79

Market Cap

486.9M

ML Signal

N/A

Company Overview

Basic Information
Metric
IRWD
ITRG
Founded
1998
1997
Country
United States
Canada
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Precious Metals
Sector
Health Care
Basic Materials
Exchange
Nasdaq
Nasdaq
Market Cap
578.3M
486.9M
IPO Year
2009
2017

Fundamental Metrics

Financial Performance
Metric
IRWD
ITRG
Price
$4.83
$1.79
Analyst Decision
Buy
Buy
Analyst Count
4
8
Target Price
★ $6.18
$5.13
AVG Volume (30 Days)
★ 2.3M
1.6M
Earning Date
11-05-2026
11-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
★ 0.91
N/A
Revenue
★ $298,276,000.00
N/A
Revenue This Year
$59.19
$10.76
Revenue Next Year
$4.80
$37.65
P/E Ratio
★ $5.33
$45.07
Revenue Growth
★ 8.88
N/A
52 Week Low
$2.95
$1.83
52 Week High
$5.78
$4.87

Technical Indicators

Market Signals
Indicator
IRWD
ITRG
Relative Strength Index (RSI) 76.30 31.12
Support Level $3.90 N/A
Resistance Level N/A $2.96
Average True Range (ATR) 0.24 0.12
MACD 0.16 -0.02
Stochastic Oscillator 93.10 7.44

Price Performance

Historical Comparison
IRWD
ITRG

About IRWD Ironwood Pharmaceuticals Inc.

Ironwood Pharmaceuticals Inc is a biotechnology company developing and commercializing life-changing therapies for people living with gastrointestinal, or GI, and rare diseases. It is focused on the development and commercialization of inventive product opportunities in areas of unmet need, leveraging its demonstrated expertise and capabilities in GI and rare diseases. LINZESS is its commercial product. LINZESS is also available for the treatment of adults with IBS-C or CIC in Mexico, adults with IBS-C or chronic constipation in Japan, and adults with IBS-C in China. Linaclotide is available under the trademarked name CONSTELLA for the treatment of adults with IBS-C or CIC and pediatric patients ages 6-17 years old with FC in Canada, and to adults with IBS-C in certain European countries.

About ITRG Integra Resources Corp.

Integra Resources Corp is a precious metals exploration and development company in the Great Basin of the Western USA. Integra is currently focused on advancing its two flagship oxide heap leach projects: the past-producing DeLamar Project located in southwestern Idaho and the Nevada North Project, comprised of the Wildcat and Mountain View deposits, located in northwestern Nevada. The company also holds a portfolio of prospective early-stage exploration projects in Idaho, Nevada, and Arizona.

Share on Social Networks: